The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug - Hardcover

9780671723279: The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
 
 
2

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Reseña del editor:
The Billion-Dollar Molecule raises the curtain on the fascinating and tumultuous drama of a radically new start-up pharmaceutical company. That company, Vertex, is trying to design a lifesaving new drug that - if it works - will prove the potential of a brand-new drug-making technique and also fulfill the vision of Vertex's founder and chairman, Joshua Boger, one of the most promising scientists of his generation.
In early 1989 the thirty-seven-year-old Boger set out to revolutionize the drug industry, the most profitable industry in existence. Trained at Harvard and at Merck, the premier biomedical firm and perennially most admired corporation in America, Boger established Vertex to design drugs atom by atom.
Barry Werth takes readers inside Vertex from its first days to profile the driven, obsessive scientists who work around the clock in pursuit of scientific breakthroughs. One member of Vertex's scientific advisory board, Stuart Schreiber, is a full professor at Harvard, younger even than Boger, and determined to win a Nobel Prize and to create new molecules that will elucidate the workings of the human cell. Schreiber, however, soon becomes Boger's chief rival in a competition between emerging scientific titans.
The immediate goal for both Vertex and Schreiber is to explore the workings of a new immunosuppressant, a drug that prevents organ transplant rejections and that could have potentially wider uses. Only one approved immune-suppressing drug exists, and it has serious side effects. If Vertex can create a better drug, it will indeed be a billion-dollar molecule.
But to succeed, Vertex needs money, lots of it. Every biotechnology story is also a Wall Street story, and Boger spends much of his time raising capital. With the assistance of the dean of venture capitalists, Benno Schmidt, Sr., Boger and his colleagues woo foreign companies eager to find American partners to help expand their presence in the U.S. pharmaceutical market. Eventually Boger decides to take Vertex public in an anxious initial public offering where, characteristically, he dominates his financial advisers.
Meanwhile, the scientific story of the elusive target molecule proves to be more complex and surprising than even Boger imagined.
This is a no-holds-barred, brilliant and compelling look at one of the key industries of our future.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

  • VerlagSimon & Schuster
  • Erscheinungsdatum1994
  • ISBN 10 0671723278
  • ISBN 13 9780671723279
  • EinbandTapa dura
  • Auflage1
  • Bewertung
Gebraucht kaufen
Zustand: Befriedigend
Good condition. Acceptable dust... Mehr zu diesem Angebot erfahren

Versand: Gratis
Innerhalb der USA

Versandziele, Kosten & Dauer

In den Warenkorb

Weitere beliebte Ausgaben desselben Titels

9780671510572: The Billion-Dollar Molecule: The Quest for the Perfect Drug (Touchstone Book)

Vorgestellte Ausgabe

ISBN 10:  ISBN 13:  9780671510572
Verlag: Simon & Schuster, 1995
Softcover

Beste Suchergebnisse beim ZVAB

Beispielbild für diese ISBN

Werth, Barry
Verlag: Simon & Schuster (1994)
ISBN 10: 0671723278 ISBN 13: 9780671723279
Gebraucht Hardcover Anzahl: 1
Anbieter:
Wonder Book
(Frederick, MD, USA)
Bewertung

Buchbeschreibung Zustand: Good. Good condition. Acceptable dust jacket. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains. Artikel-Nr. G02D-02477

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Gebraucht kaufen
EUR 7,32
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb der USA
Versandziele, Kosten & Dauer